Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers
Open accessAbstract
Background. There is a growing interest in the use of psychedelic substances for health related purposes, including symptom relief for disorders like anxiety, depression, and pain. Although the focus of recent clinical trials has been on high doses of these substances, anecdotal evidence suggests that low (micro) doses are also effective, and may be more suitable for certain conditions. Nonetheless, empirical evidence regarding the efficacy of microdosing with psychedelics for symptomatic relief is lacking.The present study aimed to investigate, by means of an online questionnaire, the self-rated effectiveness (SRE) of microdosing with psychedelics (MDP) for mental and physiological disorders compared to the conventional prescribed treatment and to regular doses of psychedelics. Methods. An online questionnaire was launched on several websites and fora between March and July 2018. Respondents who had consented, were 18 years of age or older, had experience with microdosing and were diagnosed with at least one mental or physiological disorder by a medical doctor or therapist (N= 410; 7.2%) were included in the analyses. Odds ratio were calculated to compared the SRE of MDP with conventional treatment, and regular psychedelic doses for mental and physiological diagnoses for each of the three effectiveness questions (“Did it work”, “Symptom disappear”, “Quality of life improved”). Results. Odds ratio showed that SRE of MDP was significantly higher compared to that of conventional treatments for both mental and physiological diagnoses; and that these effects were specific for neurodevelopmental and anxiety disorders. In contrast, SRE of MDP was lower compared to that of higher, regular psychedelic doses for mental disorders such as anxiety and depression, while for physiological disorders no difference was shown. Conclusion. This study demonstrates that SRE of MDP to alleviate symptoms of a range of mental or physiological diagnoses is higher compared to conventionally offered treatment options, and lower than regular (‘full’) psychedelic doses. Future RCTs in patient populations should objectively assess the effectivity claims of psychedelics, and whether these are dose related, disorder specific and superior to conventional treatments.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Some adults diagnosed with ADHD report using low, sub-hallucinogenic doses of psychedelic substances repeatedly (microdosing) to self-treat their symptoms and improve daily life functioning.
“Survey research has shown that some adults diagnosed with ADHD report using low, sub-hallucinogenic doses of psychedelic substances repeatedly, referred to as microdosing (MD), to self-treat their symptoms and as such to improve daily life functioning (4–7).”
From Trait mindfulness and personality characteristics in a microdosing ADHD sample: a naturalistic prospective survey study (2023) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391 · see citing works
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201 · cited 1× · see citing works
“Specifically, clinical trials assessing the efficacy of full, regular doses of psychedelics on treatment resistant depression (28) and end of life depression and anxiety (13, 29, 30) have found an association between the acute quality of the experience (including occurrence of profound psychological ‘peak’ or ‘mystica…”
BackgroundPeduzzi, P., Concato, J., Feinstein, A. R., & Holford, T. R. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00048-8 · Cited by 2,154 · see citing works
Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698 · see citing works
Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540 · see citing works
Palhano-Fontes, F., Barreto, D., Onias, H., Andrade, K. C., Novaes, M. M., Pessoa, J. A., Mota-Rolim, S. A., Osório, F. L., Sanches, R., dos Santos, R. G., et al. (2019) · Psychological Medicine · doi:10.1017/s0033291718001356 · Cited by 852 · see citing works
Roseman, L., Nutt, D. J., & Carhart-Harris, R. L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00974 · Cited by 808 · see citing works
Gasser, P., Holstein, D., Michel, Y., Doblin, R., Yazar-Klosinski, B., Passie, T., & Brenneisen, R. (2014) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000113 · Cited by 750 · see citing works
Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., & Doblin, R. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110378371 · Cited by 674 · see citing works
Leitner, Y. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00268 · Cited by 439 · see citing works
Mithoefer, M. C., Mithoefer, A. T., Feduccia, A. A., Jerome, L., Wagner, M., Wymer, J., Holland, J., Hamilton, S., Yazar-Klosinski, B., Emerson, A., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30135-4 · Cited by 439 · see citing works
Phenomenology, Structure, and Dynamic of Psychedelic States
Preller, K. H., & Vollenweider, F. X. (2016) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2016_459 · Cited by 282 · see citing works
Kuypers, K., Ng, L., Erritzoe, D., Knudsen, G., Nichols, C. D., Nichols, D. E., Pani, L., Soula, A., & Nutt, D. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119857204 · Cited by 188 · see citing works
Powerful substances in tiny amounts: An interview study of psychedelic microdosing
Johnstad, P. G. (2018) · Nordic Studies on Alcohol and Drugs · doi:10.1177/1455072517753339 · Cited by 155 · cited 2× · see citing works
“These findings are in line with anecdotal reports and interview studies reporting the use of psychedelic microdoses to substitute conventional prescribed medications (11, 12, 26).”
ResultStudy of Lysergic Acid Diethylamide as an Analgesic Agent
KAST, E. C., & COLLINS, V. J. (1964) · Anesthesia & Analgesia · doi:10.1213/00000539-196405000-00013 · Cited by 142 · see citing works
The Psychedelic Explorer's Guide: Safe, Therapeutic, and Sacred Journeys
Fadiman, J. (2011) · Cited by 141 · see citing works
Motives and Side-Effects of Microdosing With Psychedelics Among Users
Hutten, N. R. P. W., Mason, N. L., Dolder, P. C., & Kuypers, K. P. C. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz029 · Cited by 126 · see citing works
Might microdosing psychedelics be safe and beneficial? An initial exploration
Fadiman, J., & Korb, S. (2019) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2019.1593561 · Cited by 125 · see citing works
Neuroticism is associated with challenging experiences with psilocybin mushrooms
Barrett, F. S., Johnson, M. W., & Griffiths, R. R. (2017) · Personality and Individual Differences · doi:10.1016/j.paid.2017.06.004 · Cited by 98 · see citing works
Greaves‐Lord, K., Ferdinand, R. F., Sondeijker, F., Dietrich, A., Oldehinkel, A. J., Rosmalen, J. G. M., Ormel, J., & Verhulst, F. C. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.12.009 · Cited by 80 · see citing works
Narrative identity, rationality, and microdosing classic psychedelics
Webb, M. E., Copes, H., & Hendricks, P. S. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.04.013 · Cited by 75 · see citing works
EEG in adults with Attention-Deficit/Hyperactivity Disorder
Clarke, A. R., Barry, R. J., Heaven, P. C. L., McCarthy, R., Selikowitz, M., & Byrne, M. K. (2008) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2008.07.001 · Cited by 74 · see citing works
Ramtekkar, U. P. (2017) · Children · doi:10.3390/children4080062 · Cited by 39 · see citing works
The Psychedelic Explorer’s Guide: Safe, Therapeutic, and Sacred Journeys
Rhead, J. (2014) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2014.948329 · Cited by 30 · see citing works
Dell’Osso, L., & Pini, S. (2012) · Clinical Practice and Epidemiology in Mental Health · doi:10.2174/1745017901208010180 · Cited by 21 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study
Cavanna, F., Muller, S. L., de la Fuente, L. A., Zamberlán, F., Palmucci, M., Janeckova, L., Kuchař, M., Pallavicini, C., & Tagliazucchi, E. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02039-0 · Cited by 148 · see citing works
Low doses of LSD acutely increase BDNF blood plasma levels in healthy volunteers
Hutten, N. R. P. W., Mason, N. L., Dolder, P. C., Theunissen, E. L., Holze, F., Liechti, M. E., Varghese, N., Eckert, A., Feilding, A., Ramaekers, J. G., et al. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00099 · Cited by 131 · see citing works
Polito, V., & Liknaitzky, P. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104706 · Cited by 113 · see citing works
A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers
Ramaekers, J. G., Hutten, N. R. P. W., Mason, N. L., Dolder, P. C., Theunissen, E. L., Holze, F., Liechti, M. E., Feilding, A., & Kuypers, K. P. C. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120940937 · Cited by 92 · see citing works
The therapeutic potential of microdosing psychedelics in depression
Kuypers, K. P. C. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320950567 · Cited by 85 · see citing works
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Zaretsky, T. G., Jagodnik, K. M., Barsic, R., Antonio, J. H., Bonanno, P. A., MacLeod, C., Pierce, C., Carney, H., Morrison, M. T., Saylor, C. F., et al. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666231027111147 · Cited by 85 · see citing works
Rootman, J. M., Kryskow, P., Harvey, K., Stamets, P. E., Santos-Brault, E., Kuypers, K. P. C., Polito, V., Bourzat, F., & Walsh, Z. (2021) · Scientific Reports · doi:10.1038/s41598-021-01811-4 · Cited by 79 · see citing works
Lea, T., Amada, N. M., Jungaberle, H., Schecke, H., Scherbaum, N., & Klein, M. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05477-0 · Cited by 76 · see citing works
Psychedelics as an emerging novel intervention in the treatment of substance use disorder: a review
Divito, A. J., & Leger, R. F. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-06009-x · Cited by 75 · see citing works
Marschall, J., Fejer, G., Lempe, P., Prochazkova, L., Kuchar, M., Hajkova, K., & van Elk, M. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211050556 · Cited by 72 · see citing works
Murphy, R. J., Sumner, R. L., Evans, W., Ponton, R., Ram, S., Godfrey, K., Forsyth, A., Cavadino, A., Naga, V. K., Smith, T., et al. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.03.013 · Cited by 67 · see citing works
Holze, F., Liechti, M. E., Hutten, N. R. P. W., Mason, N. L., Dolder, P. C., Theunissen, E. L., Duthaler, U., Feilding, A., Ramaekers, J. G., & Kuypers, K. P. C. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2057 · Cited by 65 · see citing works
Oña, G., & Bouso, J. C. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.09.035 · Cited by 58 · see citing works
Microdosing psilocybin for chronic pain: a case series
Lyes, M., Yang, K. H., Castellanos, J. P., & Furnish, T. J. (2022) · Pain · doi:10.1097/j.pain.0000000000002778 · Cited by 56 · see citing works
van Elk, M., Fejer, G., Lempe, P., Prochazkova, L., Kuchař, M., Hájková, K., & Marschall, J. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05857-0 · Cited by 52 · see citing works
Kiilerich, K. F., Lorenz, J., Scharff, M. B., Speth, N., Brandt, T. G., Czurylo, J., Xiong, M., Jessen, N. S., Casado-Sainz, A., Shalgunov, V., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02280-z · Cited by 46 · see citing works
Carbonaro, T. M., Johnson, M. W., & Griffiths, R. R. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05533-9 · Cited by 49 · see citing works
Motives for the use of serotonergic psychedelics: A systematic review
Basedow, L. A., & Kuitunen‐Paul, S. (2022) · Drug and Alcohol Review · doi:10.1111/dar.13480 · Cited by 41 · see citing works
Greater subjective effects of a low dose of LSD in participants with depressed mood
Molla, H. M., Lee, R., Tare, I., & de Wit, H. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01772-4 · Cited by 41 · see citing works
Murray, C. H., Frohlich, J., Haggarty, C. J., Tare, I., Lee, R., & de Wit, H. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01809-2 · Cited by 36 · see citing works
McIntyre, R. S., Kwan, A. T. H., Mansur, R. B., Oliveira-Maia, A. J., Teopiz, K. M., Maletic, V., Suppes, T. M., Stahl, S. M., & Rosenblat, J. D. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230902 · Cited by 32 · see citing works
Bonnelle, V., Smith, W., Mason, N. L., Cavarra, M., Kryskow, P., Kuypers, K. P. C., Ramaekers, J. G., & Feilding, A. (2022) · British Journal of Pain · doi:10.1177/20494637221114962 · Cited by 26 · see citing works
Meade, E., Hehir, S., Rowan, N. J., & Garvey, M. (2022) · Journal of Fungi · doi:10.3390/jof8030290 · Cited by 24 · see citing works
Bornemann, J. (2020) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2020.1761573 · Cited by 24 · see citing works
Murphy, R. J., Sumner, R. L., Evans, W., Menkes, D. B., Lambrecht, I., Ponton, R., Sundram, F., Hoeh, N. R., Ram, S., Reynolds, L., et al. (2021) · Trials · doi:10.1186/s13063-021-05243-3 · Cited by 23 · see citing works
Inter-individual variability in neural response to low doses of LSD
Hutten, N. R. P. W., Quaedflieg, C. W. E. M., Mason, N. L., Theunissen, E. L., Liechti, M. E., Duthaler, U., Kuypers, K. P. C., Bonnelle, V., Feilding, A., & Ramaekers, J. G. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03013-8 · Cited by 21 · see citing works
Haijen, E. C. H. M., Hurks, P. P. M., & Kuypers, K. P. C. (2022) · Neuroscience Applied · doi:10.1016/j.nsa.2022.101012 · Cited by 20 · see citing works
Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults
Mueller, L., de Jesus, J. S., Schmid, Y., Müller, F., Becker, A., Klaiber, A., Straumann, I., Luethi, D., Haijen, E. C. H. M., Hurks, P. P. M., et al. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.0044 · Cited by 20 · see citing works
Natural language signatures of psilocybin microdosing
Sanz, C., Cavanna, F., Muller, S. L., de la Fuente, L., Zamberlán, F., Palmucci, M., Janeckova, L., Kuchař, M., Carrillo, F., García, A. M., et al. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06170-0 · Cited by 19 · see citing works
Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research
Polito, V., & Liknaitzky, P. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241254831 · Cited by 19 · see citing works
Basedow, L. A., Majić, T., Hafiz, N. J., Algharably, E. A. E., Kreutz, R. H., & Riemer, T. (2024) · Scientific Reports · doi:10.1038/s41598-024-65391-9 · Cited by 19 · see citing works
Psychedelics and schizophrenia: a double-edged sword
Sapienza, J., Martini, F., Comai, S., Cavallaro, R., Spangaro, M., Gregorio, D. D., & Bosia, M. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02743-x · Cited by 15 · see citing works
Wong, S., Yu, A. Y., Fabiano, N., Finkelstein, O., Pasricha, A., Jones, B. D. M., Rosenblat, J. D., Blumberger, D. M., Mulsant, B. H., & Husain, M. I. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2023.2251133 · Cited by 14 · see citing works
Experiences of microdosing psychedelics in an attempt to support wellbeing and mental health
Ryan, R. S., Copello, A. G., & Fox, A. P. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04628-9 · Cited by 12 · see citing works
Haijen, E. C. H. M., Hurks, P. P. M., & Kuypers, K. P. C. (2024) · European Psychiatry · doi:10.1192/j.eurpsy.2024.8 · Cited by 12 · see citing works
Less is more? A review of psilocybin microdosing
Savides, I. A., & Outhoff, K. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241278769 · Cited by 12 · see citing works
Deep CANALs: a deep learning approach to refining the canalization theory of psychopathology
Juliani, A., Safron, A., & Kanai, R. (2024) · Neuroscience of Consciousness · doi:10.1093/nc/niae005 · Cited by 12 · see citing works
Wells, A., Muthukumaraswamy, A. P. S., Morunga, E., Evans, W. J., Cavadino, A., Bansal, M., Lawrence, N. J., Ashley, A., Hoeh, N., Sundram, F., et al. (2024) · Pilot and Feasibility Studies · doi:10.1186/s40814-024-01449-9 · Cited by 10 · see citing works
Self-medication with Novel Psychoactive Substances (NPS): a Systematic Review
Holborn, T., Page, R. L., II, Schifano, F., & Deluca, P. (2023) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-023-01195-8 · Cited by 7 · see citing works
Cavanna, F., Muller, S. L., de la Fuente, L. A., Zamberlán, F., Palmucci, M., Janeckova, L., Kuchař, M., Pallavicini, C., & Tagliazucchi, E. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.30.470657 · Cited by 7 · see citing works
Haijen, E. C. H. M., Hurks, P. P. M., & Kuypers, K. P. C. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1233585 · Cited by 7 · see citing works
Between enhancement and risk: A critical review of psychedelic microdosing
Totomanova, I., Haijen, E. C. H. M., Hurks, P. P. M., Ramaekers, J. G., & Kuypers, K. P. C. (2025) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2025.102129 · Cited by 6 · see citing works
The Use of Novel Stimulants in ADHD Self-Medication: A Mixed Methods Analysis
Holborn, T., Schifano, F., Smith, E., & Deluca, P. (2025) · Brain Science · doi:10.3390/brainsci15030292 · Cited by 5 · see citing works
Using Psychedelics in Clinical Practice: Comparing Therapeutic Uses and Potential Harms
Tariq, R. (2022) · Current Clinical Pharmacology · doi:10.2174/2772432817666220321142707 · Cited by 5 · see citing works
Walker, C., Piatkowski, T. M., Ferris, J., Davies, E., Barratt, M. J., WINSTOCK, A. R., & Puljević, C. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241265762 · Cited by 5 · see citing works
Kiilerich, K. F., Lorenz, J., Scharff, M. B., Speth, N., Brandt, T. G., Czurylo, J., Xiong, M., Jessen, N. S., Casado-Sainz, A., Shalgunov, V., et al. (2023) · doi:10.31219/osf.io/gy6m9 · Cited by 5 · see citing works
Oblak, A., Hudnik, L. K., Levačić, A., Elersič, K., Pregelj, P., & Bon, J. (2024) · Philosophical Psychology · doi:10.1080/09515089.2024.2393690 · Cited by 4 · see citing works
Microdosing Psychedelics as a Promising New Pharmacotherapeutic
Kuypers, K. P. C. (2021) · Springer eBooks · doi:10.1007/978-3-030-62351-7_18 · Cited by 4 · see citing works
Noback, M. N., Kenton, J. A., Klein, A. K., Hughes, Z. A., Kruegel, A. C., Schmid, Y., Halberstadt, A. L., & Young, J. W. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110334 · Cited by 3 · see citing works
A bibliometric analysis of research on psychedelics for depression treatment
Hua, H., Fu, X., Wang, W., Wang, S., Wang, D., Wu, Z., Zhang, Q., He, T., & Yang, C. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e36886 · Cited by 3 · see citing works
Intersections of Psychedelics, Mystical Experiences, and Hypnosis
Elkins, G. R. (2025) · International Journal of Clinical and Experimental Hypnosis · doi:10.1080/00207144.2025.2554387 · Cited by 2 · see citing works
Drange, S., Cohen, J., Johansen, S., Dunkley, B., & Palner, M. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1819962 · Cited by 2 · see citing works
Holborn, T., Schifano, F., Smith, E., & Deluca, P. (2025) · Psychoactives · doi:10.3390/psychoactives4030028 · Cited by 2 · see citing works
Polito, V., & Liknaitzky, P. (2021) · doi:10.31234/osf.io/edhqz · Cited by 2 · see citing works
Is Microdosing a Placebo?Preprint
Polito, V., & Liknaitzky, P. (2023) · doi:10.31234/osf.io/3ykst · Cited by 2 · see citing works
Cavarra, M., Hutten, N. R. P. W., Schepers, J., Mason, N. L., Theunissen, E. L., Liechti, M. E., Kuypers, K. P. C., Bonnelle, V., Feilding, A., & Ramaekers, J. G. (2025) · British Journal of Pain · doi:10.1177/20494637251371626 · Cited by 1 · see citing works
Pierre, M. S., Argento, E., Cates, J., Kryskow, P., Harvey, K., Stamets, P. E., Santos-Brault, E., Paschall, S. A., Kuypers, K. P. C., Rootman, J. M., et al. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06913-9 · Cited by 1 · see citing works
Kazdan, J., Ladha, K. S., & Husain, M. I. (2026) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70238 · Cited by 1 · see citing works
Petranker, R., Syed, O. A., Sobolenko, V., Giacobbe, P., Kruger, D. J., Aday, J. S., Lake, S., & Lucas, P. (2026) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2026.105459 · Cited by 1 · see citing works
Do undergraduates’ views of psychedelics relate to the context for psychedelic use?
Petrovitch, D., Allen, J. V., Mitchell, S. M., & Littlefield, A. K. (2025) · Drug Science Policy and Law · doi:10.1177/20503245241308747 · Cited by 1 · see citing works
The good, the bad, and the intoxicated
Mason, N. L. (2021) · doi:10.26481/dis.20210608nm
Therapeutic Choice in the SUDs Treatment
Horák, M., & Verter, N. (2022) · Springer eBooks · doi:10.1007/978-3-031-16459-0_17
Aplicações terapêuticas e benéficas do LSD: uma revisão sistemática
Marson, M. A. G., Neto, J. V. D. P., Zaniratto, J., & Borges, K. K. (2023) · Peer Review · doi:10.53660/516.prw1503b
Ferreira, A. S. M., Martindale, S., & Luke, D. P. (2024) · Journal of Psychedelic Studies · doi:10.1556/2054.2024.00368
Microdosing Psychedelics as a Promising New Pharmacotherapeutic
Kuypers, K. P. C. (2024) · Springer eBooks · doi:10.1007/978-3-031-61992-2_26
Totomanova, I., Haijen, E. C. H. M., Hurks, P. P. M., Ramaekers, J. G., & Kuypers, K. P. C. (2025) · International review of neurobiology · doi:10.1016/bs.irn.2025.03.002
Murphy, R. J., Wardlaw, M., Smith, T., Noorani, T. N., Evans, W., Reynolds, L., Menkes, D. B., Sumner, R. L., & Muthukumaraswamy, S. D. (2025) · Journal of Humanistic Psychology · doi:10.1177/00221678251382624
Donegan, C. J., Daldegan‐Bueno, D., Sumner, R. L., Forsyth, A., Evans, W., Hoeh, N. R., Sundram, F., Menkes, D. B., Muthukumaraswamy, S. D., & Reynolds, L. (2025) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253251396253
Ryan, R. S., Copello, A., & Fox, A. P. (2024) · Figshare · doi:10.6084/m9.figshare.26575175
Murphy, R. J., Sumner, R. L., Evans, W. J., Menkes, D., Lambrecht, I., Ponton, R., Sundram, F., Hoeh, N. R., Ram, S., Reynolds, L., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14478492
Microdoses de psicodélicos no tratamento de transtornos mentais: uma revisão sistemática
Cavalcante, G. J. C. S., Magrini, A. T., Rigelli, R. H., Dendasck, C. V., Dias, C. A. G. D. M., de Araújo, M. H. M., & Fecury, A. A. (2025) · Revista Científica Multidisciplinar Núcleo do Conhecimento · doi:10.32749/nucleodoconhecimento.com.br/saude/microdoses-de-psicodelicos
Devaluation and Revaluation as Dynamic Social Processes: The Case of Psychedelic Stigma
Farrimond, H. R., & Michael, M. (2026) · Sociology of Health & Illness · doi:10.1111/1467-9566.70200
Haijen, E. C. H. M., Hurks, P. P. M., Schepers, J., Vizeli, P., de Jesus, J. S., Mueller, L., Schmid, Y., Liechti, M. E., & Kuypers, K. P. C. (2026) · Psychopharmacology · doi:10.1007/s00213-026-07107-7
Enriquez‐Geppert, S., Bevers, L., Rosander, A., Fodran, P., & Polito, V. (2026) · Biomolecules · doi:10.3390/biom16070983
Giovenzana, M., Nicosia, N., Spinosa, S., Musazzi, L., & Mingardi, J. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108366
Kelly, C., Cooley, B. J., Zeng, L., Hurzeler, T. P., Manning, V., McNally, G. P., Watt, J., Haber, P., & Morley, K. C. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106911
Adamou, M., & Petrou, C. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1966206
- Authors
- Hutten, N. R. P. W., Mason, N. L., Dolder, P. C., & Kuypers, K. P. C.
- Affiliations
- Maastricht University (NL)
- Corresponding author
- Hutten, Nadia R. P. W.
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2019-09-13
- Volume
- 10
- Pages
- 672-672
- ISSN
- 1664-0640 (ISSN-L)
- PMC
- PMC6753862
- OpenAlex
- W2969627127
- Cited by
- 77
- References
- 25
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 16 · 2023: 10 · 2022: 10 · 2021: 9 · 2020: 9
- FWCI
- 8.18
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Psychiatry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Social Sciences › Psychology › Social Psychology › Paranormal Experiences and Beliefs
- Social Sciences › Health › Religion, Spirituality, and Psychology
- Keywords
- microdosing, psychedelics, mental illness, physical disorders, anxiety disorders, neurodevelopmental disorders, depression, symptom relief, quality of life, conventional therapy comparison, dose comparison
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
